Corporate Overview, Investor’s Portal – PPM, Financial Highlights, Flipbook: Seed Funding Deck, Regulatory & Compliance, Recent News & updates, Documents & Downloads, Contact Investor Relation

 “Congratulations, Welcome to the AiLc Investor Portal.”

PPM – Seed Funding – Series A – Corporate / 6 SPVs – Centers / 12 SPVs

1. PPM – Seed Funding round details
2. PPM – Planned Series A / Future rounds
3. PPM – Corporate; a) Equipment Leasing, b) AILc HealthOS2 (App), c) Humanoid Team Members d) Mobile Medical Centers e) Franchise Program, f) “Medical Research”   
4. PPM – Centers; Florida District 1: Miami-Dade, District 3: Orlando 
5. PPM – Investment timeline and key milestones

👉 AiLc – 3rd & 4th Quarter 2005 Financial Summary

Seed Funding round Details

AI Longevity Clinic, Inc. is currently conducting its Seed Funding Round, targeting strategic investors aligned with our mission to revolutionize preventive healthcare through AI. The raise seeks $500k in capital, offering equity participation at a ground-floor valuation with substantial upside as we acquire licensed medical centers and scale operations. Proceeds will be used for clinic buildouts, AI infrastructure, regulatory compliance, and working capital. Early investors gain preferred share status, board-level access, and participation in our SPAC’s long-term public market roadmap. This is a rare opportunity to help shape the future of longevity medicine from inception

2. Planned Series A / Future rounds

Following a successful Seed Round, AI Longevity Clinic, Inc. is preparing for its Series A funding round, projected for 1st Quarter 2026. This round will focus on accelerating multi-site clinic expansion, advancing AI-driven diagnostics, and launching our Longevity-as-a-Service™ platform. Future rounds will support international growth, strategic acquisitions, and the build-out of our proprietary data infrastructure. Series A investors will benefit from enhanced equity positions, milestone-based incentives, and first-tier access to upcoming SPAC merger discussions. Our long-term capital strategy is designed to deliver exponential growth and position AI Longevity Clinic as a global leader in precision aging.

3. Minimum investment amount

AI Longevity Clinic, Inc. welcomes early-stage investors who share our vision for transforming healthcare through AI-driven longevity. The minimum investment for participation in the Seed Funding Round is $500,000. This threshold ensures strategic alignment and allows investors to access preferred equity terms, milestone updates, and VIP previews of future Series A opportunities. Accredited investors may also qualify for advisory board invitations and early participation in our clinical technology rollouts. All investments are governed by a transparent subscription agreement and reviewed for compliance with SEC regulations.

4. Use of Funds 

Capital raised during the Seed and Series A rounds will be strategically allocated to drive the expansion of AI Longevity Clinic, Inc. Funds will support the buildout of medical facilities, integration of AI diagnostic technologies, licensing and regulatory approvals, hiring of medical and executive staff, and the development of our proprietary Longevity-as-a-Service™ platform. Additional funding will be used to enhance marketing, investor relations, and infrastructure for digital health data compliance. Every dollar is deployed with a focus on rapid scalability, clinical excellence, and delivering measurable value to both patients and shareholders.

5. Investment Timeline and Key Milestones

AI Longevity Clinic, Inc. follows a strategic capital deployment plan aligned with defined performance benchmarks. The investment timeline spans a 24-month runway, with key milestones including: Seed Round close (Q2 2025), Series A launch (Q3 2025), opening of 3 flagship clinics (Q1 2026), full rollout of Longevity-as-a-Service™ (Q2 2026), and IPO readiness by Q4 2026. Each stage is tied to investor reporting, audited financials, and milestone-triggered investor updates. This timeline ensures transparency, accountability, and scalable growth across the AI Longevity ecosystem.